Larvol Delta - AltruBio-moves-forward-with-clinical-development-of-Neihulizumab-in-SteroidRefractory-Acute-GraftversusHost-Disease-after-encouraging-Phase-1a-results

neihulizumab (AbGn-168H) - AbGenomics

https://pipelinereview.com/index.php/2020070275202/DNA-RNA-and-Cells/AltruBio-moves-forward-with-clinical-development-of-Neihulizumab-in-Steroid-Refractory-Acute-Graft-versus-Host-Disease-after-encouraging-Phase-1a-results.html

Jul 2, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next